Hologic (HOLX) Hisse Fiyat
Hologic Fiyat
Hologic, son 19 yılda gelirini yıllık %12,2 artırarak 4,10 Md USD seviyesine taşıdı. Hisse başına kâr, son 19 yılda yıllık %12,8 büyüdü. Hologic için net marj, %13,8 ile birkaç yıl önceki %33,2 seviyesine göre geriledi. Hologic için 12 aylık konsensüs fiyat hedefi 77,52 USD; bu, hissenin bugünkü fiyatının yaklaşık %2,0 üzerinde bir seviyeye denk geliyor. 23 analistten 0 tanesi hisse için alım öneriyor — genel konsensüs: Tut.
Hologic hisse senedi fiyatı
Hologic iş modeli ve hisse analizi
Hologic hakkında sık sorulan sorular
The main competitors of Hologic Inc in the market include companies like Abbott Laboratories, Thermo Fisher Scientific, and Becton, Dickinson and Company.
The business model of Hologic Inc revolves around providing innovative diagnostic solutions, primarily focused on women's healthcare. Hologic develops and markets a wide range of medical devices and instruments, including imaging systems, surgical products, and molecular diagnostic assays. The company's products are designed to enable healthcare professionals to effectively screen, diagnose, and treat various conditions and diseases. Hologic is renowned for its advanced technologies in breast health, gynecology, and skeletal health, offering solutions that empower early detection and intervention. By constantly pushing the boundaries of medical technology, Hologic Inc remains committed to improving healthcare outcomes for women around the world.
Hologic Inc is primarily active in the healthcare industry, specifically in the field of diagnostic products and medical devices. With a focus on improving women's health, Hologic Inc develops and manufactures a wide range of innovative solutions. Their portfolio includes advanced imaging systems, molecular diagnostic assays, surgical instruments, and women's health screening tests. As a prominent player in the healthcare sector, Hologic Inc constantly strives to provide cutting-edge technologies and solutions to address various medical challenges.
Hologic Inc is a leading global healthcare and diagnostics company. Established in 1985, Hologic has excelled in providing innovative solutions for women's health, with a focus on early detection and treatment of breast and cervical cancers. The company's dedication to research and development has resulted in breakthrough technologies, including the introduction of the first 3D mammography system. Hologic has expanded its portfolio to include diagnostics, surgical and skeletal health, and GYN surgical products. With a strong commitment to advancing healthcare, Hologic Inc continues to make significant contributions to improving patient outcomes and quality of life.
Hologic Inc, a leading healthcare company, has achieved several significant milestones. In recent years, the company has made notable advancements in breast health solutions. They introduced the world's first 3D mammography system, which revolutionized breast cancer detection by providing clearer and more accurate images. Hologic Inc also developed the Genius™ 3D Mammography™ exam, proven to detect breast cancer at an earlier stage compared to 2D mammography alone. Furthermore, the company expanded its portfolio by acquiring Gen-Probe, a molecular diagnostics company, allowing Hologic Inc to offer a comprehensive range of diagnostic solutions. These milestones highlight Hologic Inc's commitment to innovation and improving women's healthcare outcomes.
Hologic Inc is primarily present in various countries and regions worldwide. The company has a significant presence in the United States, where it is headquartered. Additionally, Hologic Inc operates in Europe, including countries like Germany, France, Italy, and the United Kingdom. It also has a presence in Asia, particularly in countries such as China and Japan. Furthermore, Hologic Inc serves customers in Canada and Latin America, with a focus on countries like Mexico and Brazil. Overall, Hologic Inc has a global reach and aims to provide its products and services to diverse markets internationally.
Hologic Inc represents values of innovation, commitment to quality, and patient-centric approach. The corporate philosophy of Hologic Inc revolves around developing cutting-edge medical technologies to improve women's health outcomes. With a focus on providing accurate and reliable diagnostic solutions, Hologic Inc strives to empower healthcare professionals and patients alike. The company's dedication to research and development, evidence-based practices, and collaboration with healthcare experts reinforces its commitment to advancing healthcare for women globally. Hologic Inc's mission is to make a difference in people's lives through advanced healthcare solutions, making them a trusted and reliable leader in the industry.
Analistler şu anda Hologic hissesi için ortalama 76,66 USD hedef fiyat belirliyor (medyan: 77,52 USD); bu, son fiyata göre +0,9 % anlamına gelir. Konsensüs 23 analist notuna dayanır.
23 analist şu anda Hologic hissesini değerlendiriyor: 0 al, 20 tut, 3 sat öneriyor. 2026 için analistler Hologic şirketinin 4,24 Md USD gelir ve 4,49 USD hisse başına kâr üretmesini bekliyor.
Güncel döviz kuruyla Hologic hissesi 67,85 EUR (76,01 USD) seviyesindedir.
Hologic hissesi (HOLX) 9 borsada işlem görür, bunlar arasında: NASDAQ (HOLX), London (0J5Q.L), SIX (Zürich) (HO1.SW), XETRA (HO1.DE), Frankfurt (HO1.F), München (HO1.MU), Düsseldorf (HO1.DU), Wien (HOLX.VI).
Hologic Inc is an international leading provider of medical technology products and solutions. The company, headquartered in Marlborough, Massachusetts, operates globally and is divided into four business segments: Diagnostics, Gynecology, Skeletal Health, and Aesthetics.
beklenen'nin Hologic hasılatı 4,24 Md USD'dir. Bu rakam, mevcut finansal verilere dayanmakta ve şirketin iş performansını yansıtmaktadır.
beklenen'nin Hologic karı 1,01 Md USD'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.
Hologic'nin Fiyat/Kazanç (F/K) oranı şu anda 16,93'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların Hologic hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.
Hologic'nin Fiyat/Satış (F/S) oranı şu anda 4,05'dir. F/S oranı, pazar kapitalizasyonunu yıllık gelirle karşılaştırır ve Hologic hisse senedinin değerleme metriği olarak hizmet eder.
Hologic'nin Eulerpool Kalite Puanı 1/10'dur.
Hologic'nin ISIN'i US4364401012'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.
Hologic'nin WKN'i 879100'dir. WKN (Wertpapierkennnummer), menkul kıymetleri tanımlamak için kullanılan altı haneli bir Alman kimlik numarasıdır.
Hologic'nin ticker'ı HOLX'dir. Ticker sembolü, Hologic hisseleri borsada işlem görmek için kullanılır.
Hologic Hissesi
Hologic Emsaller Grubu
Hologic Ticker
Hologic FIGI
Hologic'nin tüm temel göstergeleri ve derinlemesine analizi
Hologic hissesine yönelik aktienanalizimiz, satış, kar, P/E oranı, P/S oranı, EBIT gibi önemli mali kriterleri içermekte olup, dividende bilgilerini de ele almaktadır. Ayrıca, hisseler, piyasa değeri, borçlar, özsermaye ve Hologic şirketin yükümlülükleri gibi konuları incelemekteyiz. Bu konular hakkında daha detaylı bilgilere ihtiyacınız varsa, web sitemizin alt sayfalarında kapsamlı analizler sunuyoruz: